<?xml version="1.0" encoding="UTF-8"?>
<mods xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.loc.gov/mods/v3" version="3.1" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-1.xsd">
  <titleInfo>
    <title>Efficacy of the nicotine vaccine 3''-AmNic-rEPA (NicVAX) co-administered with varenicline and counselling for smoking cessation: a randomized placebo-controlled trial</title>
  </titleInfo>
  <name type="personal">
    <namePart>Hoogsteder, P.H.J.</namePart>
    <role>
      <roleTerm authority="marcrelator" type="text">creator</roleTerm>
    </role>
  </name>
  <name type="personal">
    <namePart>et al.</namePart>
  </name>
  <typeOfResource>text</typeOfResource>
  <genre authority="">Documental</genre>
  <originInfo>
    <place>
      <placeTerm type="code" authority="marccountry">sp</placeTerm>
    </place>
    <dateIssued encoding="marc">2014</dateIssued>
    <issuance>monographic</issuance>
  </originInfo>
  <language>
    <languageTerm authority="iso639-2b" type="code">spa</languageTerm>
  </language>
  <language>
    <languageTerm authority="iso639-2b" type="code">eng</languageTerm>
  </language>
  <targetAudience authority="marctarget">general</targetAudience>
  <subject>
    <topic>Drogodependencias</topic>
  </subject>
  <subject>
    <topic>Efectos</topic>
  </subject>
  <subject>
    <topic>Evaluación de servicios</topic>
  </subject>
  <subject>
    <topic>Fármacos</topic>
  </subject>
  <subject>
    <topic>Innovaciones</topic>
  </subject>
  <subject>
    <topic>Nicotina</topic>
  </subject>
  <subject>
    <topic>Resultados</topic>
  </subject>
  <subject>
    <topic>Tabaco</topic>
  </subject>
  <subject>
    <topic>Tabaquismo</topic>
  </subject>
  <subject>
    <topic>Tratamiento</topic>
  </subject>
  <subject>
    <topic>Tratamiento médico</topic>
  </subject>
  <subject>
    <topic>Vacunas</topic>
  </subject>
  <subject>
    <topic>Adicciones</topic>
  </subject>
  <relatedItem type="host">
    <titleInfo>
      <title>Addiction</title>
    </titleInfo>
    <part>
      <text>Vol. 109, no. 8 (2014), p. 1252-1259</text>
    </part>
  </relatedItem>
  <identifier type="issn">0965-2140 (papel)</identifier>
  <identifier type="issn">1360-0443 (online)</identifier>
  <identifier type="uri">10.1111/add.12573</identifier>
  <identifier type="uri">\\Srvdatos\siis\docus\Revistas electrónicas\Addiction R.696\2014\Efficacy of the nicotine vaccine 3'-AmNic-rEPA.pdf</identifier>
  <location>
    <url>10.1111/add.12573</url>
  </location>
  <location>
    <url>\\Srvdatos\siis\docus\Revistas electrónicas\Addiction R.696\2014\Efficacy of the nicotine vaccine 3'-AmNic-rEPA.pdf</url>
  </location>
  <recordInfo>
    <recordCreationDate encoding="marc">141020</recordCreationDate>
    <recordChangeDate encoding="iso8601">20170103142049.0</recordChangeDate>
  </recordInfo>
</mods>
